Global Vaccines Administered Orally Market Growth 2023-2028

Report ID: 1344787 | Published Date: Jan 2025 | No. of Page: 112 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Vaccines Administered Orally Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Vaccines Administered Orally by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Vaccines Administered Orally by Country/Region, 2017, 2022 & 2028
    2.2 Vaccines Administered Orally Segment by Type
        2.2.1 Human
        2.2.2 Animal
    2.3 Vaccines Administered Orally Sales by Type
        2.3.1 Global Vaccines Administered Orally Sales Market Share by Type (2017-2022)
        2.3.2 Global Vaccines Administered Orally Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Vaccines Administered Orally Sale Price by Type (2017-2022)
    2.4 Vaccines Administered Orally Segment by Application
        2.4.1 Public
        2.4.2 Private
    2.5 Vaccines Administered Orally Sales by Application
        2.5.1 Global Vaccines Administered Orally Sale Market Share by Application (2017-2022)
        2.5.2 Global Vaccines Administered Orally Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Vaccines Administered Orally Sale Price by Application (2017-2022)
3 Global Vaccines Administered Orally by Company
    3.1 Global Vaccines Administered Orally Breakdown Data by Company
        3.1.1 Global Vaccines Administered Orally Annual Sales by Company (2020-2022)
        3.1.2 Global Vaccines Administered Orally Sales Market Share by Company (2020-2022)
    3.2 Global Vaccines Administered Orally Annual Revenue by Company (2020-2022)
        3.2.1 Global Vaccines Administered Orally Revenue by Company (2020-2022)
        3.2.2 Global Vaccines Administered Orally Revenue Market Share by Company (2020-2022)
    3.3 Global Vaccines Administered Orally Sale Price by Company
    3.4 Key Manufacturers Vaccines Administered Orally Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Vaccines Administered Orally Product Location Distribution
        3.4.2 Players Vaccines Administered Orally Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Vaccines Administered Orally by Geographic Region
    4.1 World Historic Vaccines Administered Orally Market Size by Geographic Region (2017-2022)
        4.1.1 Global Vaccines Administered Orally Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Vaccines Administered Orally Annual Revenue by Geographic Region
    4.2 World Historic Vaccines Administered Orally Market Size by Country/Region (2017-2022)
        4.2.1 Global Vaccines Administered Orally Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Vaccines Administered Orally Annual Revenue by Country/Region
    4.3 Americas Vaccines Administered Orally Sales Growth
    4.4 APAC Vaccines Administered Orally Sales Growth
    4.5 Europe Vaccines Administered Orally Sales Growth
    4.6 Middle East & Africa Vaccines Administered Orally Sales Growth
5 Americas
    5.1 Americas Vaccines Administered Orally Sales by Country
        5.1.1 Americas Vaccines Administered Orally Sales by Country (2017-2022)
        5.1.2 Americas Vaccines Administered Orally Revenue by Country (2017-2022)
    5.2 Americas Vaccines Administered Orally Sales by Type
    5.3 Americas Vaccines Administered Orally Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Vaccines Administered Orally Sales by Region
        6.1.1 APAC Vaccines Administered Orally Sales by Region (2017-2022)
        6.1.2 APAC Vaccines Administered Orally Revenue by Region (2017-2022)
    6.2 APAC Vaccines Administered Orally Sales by Type
    6.3 APAC Vaccines Administered Orally Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Vaccines Administered Orally by Country
        7.1.1 Europe Vaccines Administered Orally Sales by Country (2017-2022)
        7.1.2 Europe Vaccines Administered Orally Revenue by Country (2017-2022)
    7.2 Europe Vaccines Administered Orally Sales by Type
    7.3 Europe Vaccines Administered Orally Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Vaccines Administered Orally by Country
        8.1.1 Middle East & Africa Vaccines Administered Orally Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Vaccines Administered Orally Revenue by Country (2017-2022)
    8.2 Middle East & Africa Vaccines Administered Orally Sales by Type
    8.3 Middle East & Africa Vaccines Administered Orally Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Vaccines Administered Orally
    10.3 Manufacturing Process Analysis of Vaccines Administered Orally
    10.4 Industry Chain Structure of Vaccines Administered Orally
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Vaccines Administered Orally Distributors
    11.3 Vaccines Administered Orally Customer
12 World Forecast Review for Vaccines Administered Orally by Geographic Region
    12.1 Global Vaccines Administered Orally Market Size Forecast by Region
        12.1.1 Global Vaccines Administered Orally Forecast by Region (2023-2028)
        12.1.2 Global Vaccines Administered Orally Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Vaccines Administered Orally Forecast by Type
    12.7 Global Vaccines Administered Orally Forecast by Application
13 Key Players Analysis
    13.1 Merck
        13.1.1 Merck Company Information
        13.1.2 Merck Vaccines Administered Orally Product Offered
        13.1.3 Merck Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Merck Main Business Overview
        13.1.5 Merck Latest Developments
    13.2 GSK
        13.2.1 GSK Company Information
        13.2.2 GSK Vaccines Administered Orally Product Offered
        13.2.3 GSK Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 GSK Main Business Overview
        13.2.5 GSK Latest Developments
    13.3 Sanofi
        13.3.1 Sanofi Company Information
        13.3.2 Sanofi Vaccines Administered Orally Product Offered
        13.3.3 Sanofi Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Sanofi Main Business Overview
        13.3.5 Sanofi Latest Developments
    13.4 Lanzhou Institute
        13.4.1 Lanzhou Institute Company Information
        13.4.2 Lanzhou Institute Vaccines Administered Orally Product Offered
        13.4.3 Lanzhou Institute Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Lanzhou Institute Main Business Overview
        13.4.5 Lanzhou Institute Latest Developments
    13.5 Serum Institute
        13.5.1 Serum Institute Company Information
        13.5.2 Serum Institute Vaccines Administered Orally Product Offered
        13.5.3 Serum Institute Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Serum Institute Main Business Overview
        13.5.5 Serum Institute Latest Developments
    13.6 Valneva
        13.6.1 Valneva Company Information
        13.6.2 Valneva Vaccines Administered Orally Product Offered
        13.6.3 Valneva Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Valneva Main Business Overview
        13.6.5 Valneva Latest Developments
    13.7 Shanghai United Cell
        13.7.1 Shanghai United Cell Company Information
        13.7.2 Shanghai United Cell Vaccines Administered Orally Product Offered
        13.7.3 Shanghai United Cell Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Shanghai United Cell Main Business Overview
        13.7.5 Shanghai United Cell Latest Developments
    13.8 Bibcol
        13.8.1 Bibcol Company Information
        13.8.2 Bibcol Vaccines Administered Orally Product Offered
        13.8.3 Bibcol Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Bibcol Main Business Overview
        13.8.5 Bibcol Latest Developments
    13.9 PaxVax
        13.9.1 PaxVax Company Information
        13.9.2 PaxVax Vaccines Administered Orally Product Offered
        13.9.3 PaxVax Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 PaxVax Main Business Overview
        13.9.5 PaxVax Latest Developments
    13.10 Vabiotech
        13.10.1 Vabiotech Company Information
        13.10.2 Vabiotech Vaccines Administered Orally Product Offered
        13.10.3 Vabiotech Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Vabiotech Main Business Overview
        13.10.5 Vabiotech Latest Developments
    13.11 Tiantan Biological
        13.11.1 Tiantan Biological Company Information
        13.11.2 Tiantan Biological Vaccines Administered Orally Product Offered
        13.11.3 Tiantan Biological Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Tiantan Biological Main Business Overview
        13.11.5 Tiantan Biological Latest Developments
    13.12 EuBiologics
        13.12.1 EuBiologics Company Information
        13.12.2 EuBiologics Vaccines Administered Orally Product Offered
        13.12.3 EuBiologics Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 EuBiologics Main Business Overview
        13.12.5 EuBiologics Latest Developments
    13.13 Panacea Biotec Ltd
        13.13.1 Panacea Biotec Ltd Company Information
        13.13.2 Panacea Biotec Ltd Vaccines Administered Orally Product Offered
        13.13.3 Panacea Biotec Ltd Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Panacea Biotec Ltd Main Business Overview
        13.13.5 Panacea Biotec Ltd Latest Developments
    13.14 Bio-Med
        13.14.1 Bio-Med Company Information
        13.14.2 Bio-Med Vaccines Administered Orally Product Offered
        13.14.3 Bio-Med Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
        13.14.4 Bio-Med Main Business Overview
        13.14.5 Bio-Med Latest Developments
    13.15 Halfkin Bio-Pharmaceuticals
        13.15.1 Halfkin Bio-Pharmaceuticals Company Information
        13.15.2 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Offered
        13.15.3 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
        13.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview
        13.15.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Vaccines Administered Orally Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Vaccines Administered Orally Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Human
    Table 4. Major Players of Animal
    Table 5. Global Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
    Table 6. Global Vaccines Administered Orally Sales Market Share by Type (2017-2022)
    Table 7. Global Vaccines Administered Orally Revenue by Type (2017-2022) & ($ million)
    Table 8. Global Vaccines Administered Orally Revenue Market Share by Type (2017-2022)
    Table 9. Global Vaccines Administered Orally Sale Price by Type (2017-2022) & (US$/Unit)
    Table 10. Global Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
    Table 11. Global Vaccines Administered Orally Sales Market Share by Application (2017-2022)
    Table 12. Global Vaccines Administered Orally Revenue by Application (2017-2022)
    Table 13. Global Vaccines Administered Orally Revenue Market Share by Application (2017-2022)
    Table 14. Global Vaccines Administered Orally Sale Price by Application (2017-2022) & (US$/Unit)
    Table 15. Global Vaccines Administered Orally Sales by Company (2020-2022) & (K Units)
    Table 16. Global Vaccines Administered Orally Sales Market Share by Company (2020-2022)
    Table 17. Global Vaccines Administered Orally Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global Vaccines Administered Orally Revenue Market Share by Company (2020-2022)
    Table 19. Global Vaccines Administered Orally Sale Price by Company (2020-2022) & (US$/Unit)
    Table 20. Key Manufacturers Vaccines Administered Orally Producing Area Distribution and Sales Area
    Table 21. Players Vaccines Administered Orally Products Offered
    Table 22. Vaccines Administered Orally Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Vaccines Administered Orally Sales by Geographic Region (2017-2022) & (K Units)
    Table 26. Global Vaccines Administered Orally Sales Market Share Geographic Region (2017-2022)
    Table 27. Global Vaccines Administered Orally Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global Vaccines Administered Orally Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global Vaccines Administered Orally Sales by Country/Region (2017-2022) & (K Units)
    Table 30. Global Vaccines Administered Orally Sales Market Share by Country/Region (2017-2022)
    Table 31. Global Vaccines Administered Orally Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global Vaccines Administered Orally Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
    Table 34. Americas Vaccines Administered Orally Sales Market Share by Country (2017-2022)
    Table 35. Americas Vaccines Administered Orally Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas Vaccines Administered Orally Revenue Market Share by Country (2017-2022)
    Table 37. Americas Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
    Table 38. Americas Vaccines Administered Orally Sales Market Share by Type (2017-2022)
    Table 39. Americas Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
    Table 40. Americas Vaccines Administered Orally Sales Market Share by Application (2017-2022)
    Table 41. APAC Vaccines Administered Orally Sales by Region (2017-2022) & (K Units)
    Table 42. APAC Vaccines Administered Orally Sales Market Share by Region (2017-2022)
    Table 43. APAC Vaccines Administered Orally Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC Vaccines Administered Orally Revenue Market Share by Region (2017-2022)
    Table 45. APAC Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
    Table 46. APAC Vaccines Administered Orally Sales Market Share by Type (2017-2022)
    Table 47. APAC Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
    Table 48. APAC Vaccines Administered Orally Sales Market Share by Application (2017-2022)
    Table 49. Europe Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
    Table 50. Europe Vaccines Administered Orally Sales Market Share by Country (2017-2022)
    Table 51. Europe Vaccines Administered Orally Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe Vaccines Administered Orally Revenue Market Share by Country (2017-2022)
    Table 53. Europe Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
    Table 54. Europe Vaccines Administered Orally Sales Market Share by Type (2017-2022)
    Table 55. Europe Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
    Table 56. Europe Vaccines Administered Orally Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
    Table 58. Middle East & Africa Vaccines Administered Orally Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa Vaccines Administered Orally Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa Vaccines Administered Orally Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
    Table 62. Middle East & Africa Vaccines Administered Orally Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
    Table 64. Middle East & Africa Vaccines Administered Orally Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of Vaccines Administered Orally
    Table 66. Key Market Challenges & Risks of Vaccines Administered Orally
    Table 67. Key Industry Trends of Vaccines Administered Orally
    Table 68. Vaccines Administered Orally Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. Vaccines Administered Orally Distributors List
    Table 71. Vaccines Administered Orally Customer List
    Table 72. Global Vaccines Administered Orally Sales Forecast by Region (2023-2028) & (K Units)
    Table 73. Global Vaccines Administered Orally Sales Market Forecast by Region
    Table 74. Global Vaccines Administered Orally Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global Vaccines Administered Orally Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas Vaccines Administered Orally Sales Forecast by Country (2023-2028) & (K Units)
    Table 77. Americas Vaccines Administered Orally Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC Vaccines Administered Orally Sales Forecast by Region (2023-2028) & (K Units)
    Table 79. APAC Vaccines Administered Orally Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe Vaccines Administered Orally Sales Forecast by Country (2023-2028) & (K Units)
    Table 81. Europe Vaccines Administered Orally Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa Vaccines Administered Orally Sales Forecast by Country (2023-2028) & (K Units)
    Table 83. Middle East & Africa Vaccines Administered Orally Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global Vaccines Administered Orally Sales Forecast by Type (2023-2028) & (K Units)
    Table 85. Global Vaccines Administered Orally Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global Vaccines Administered Orally Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global Vaccines Administered Orally Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global Vaccines Administered Orally Sales Forecast by Application (2023-2028) & (K Units)
    Table 89. Global Vaccines Administered Orally Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global Vaccines Administered Orally Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global Vaccines Administered Orally Revenue Market Share Forecast by Application (2023-2028)
    Table 92. Merck Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
    Table 93. Merck Vaccines Administered Orally Product Offered
    Table 94. Merck Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 95. Merck Main Business
    Table 96. Merck Latest Developments
    Table 97. GSK Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
    Table 98. GSK Vaccines Administered Orally Product Offered
    Table 99. GSK Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 100. GSK Main Business
    Table 101. GSK Latest Developments
    Table 102. Sanofi Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
    Table 103. Sanofi Vaccines Administered Orally Product Offered
    Table 104. Sanofi Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 105. Sanofi Main Business
    Table 106. Sanofi Latest Developments
    Table 107. Lanzhou Institute Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
    Table 108. Lanzhou Institute Vaccines Administered Orally Product Offered
    Table 109. Lanzhou Institute Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 110. Lanzhou Institute Main Business
    Table 111. Lanzhou Institute Latest Developments
    Table 112. Serum Institute Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
    Table 113. Serum Institute Vaccines Administered Orally Product Offered
    Table 114. Serum Institute Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 115. Serum Institute Main Business
    Table 116. Serum Institute Latest Developments
    Table 117. Valneva Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
    Table 118. Valneva Vaccines Administered Orally Product Offered
    Table 119. Valneva Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 120. Valneva Main Business
    Table 121. Valneva Latest Developments
    Table 122. Shanghai United Cell Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
    Table 123. Shanghai United Cell Vaccines Administered Orally Product Offered
    Table 124. Shanghai United Cell Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 125. Shanghai United Cell Main Business
    Table 126. Shanghai United Cell Latest Developments
    Table 127. Bibcol Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
    Table 128. Bibcol Vaccines Administered Orally Product Offered
    Table 129. Bibcol Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 130. Bibcol Main Business
    Table 131. Bibcol Latest Developments
    Table 132. PaxVax Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
    Table 133. PaxVax Vaccines Administered Orally Product Offered
    Table 134. PaxVax Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 135. PaxVax Main Business
    Table 136. PaxVax Latest Developments
    Table 137. Vabiotech Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
    Table 138. Vabiotech Vaccines Administered Orally Product Offered
    Table 139. Vabiotech Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 140. Vabiotech Main Business
    Table 141. Vabiotech Latest Developments
    Table 142. Tiantan Biological Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
    Table 143. Tiantan Biological Vaccines Administered Orally Product Offered
    Table 144. Tiantan Biological Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 145. Tiantan Biological Main Business
    Table 146. Tiantan Biological Latest Developments
    Table 147. EuBiologics Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
    Table 148. EuBiologics Vaccines Administered Orally Product Offered
    Table 149. EuBiologics Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 150. EuBiologics Main Business
    Table 151. EuBiologics Latest Developments
    Table 152. Panacea Biotec Ltd Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
    Table 153. Panacea Biotec Ltd Vaccines Administered Orally Product Offered
    Table 154. Panacea Biotec Ltd Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 155. Panacea Biotec Ltd Main Business
    Table 156. Panacea Biotec Ltd Latest Developments
    Table 157. Bio-Med Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
    Table 158. Bio-Med Vaccines Administered Orally Product Offered
    Table 159. Bio-Med Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 160. Bio-Med Main Business
    Table 161. Bio-Med Latest Developments
    Table 162. Halfkin Bio-Pharmaceuticals Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
    Table 163. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Offered
    Table 164. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 165. Halfkin Bio-Pharmaceuticals Main Business
    Table 166. Halfkin Bio-Pharmaceuticals Latest Developments
List of Figures
    Figure 1. Picture of Vaccines Administered Orally
    Figure 2. Vaccines Administered Orally Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Vaccines Administered Orally Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Vaccines Administered Orally Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Vaccines Administered Orally Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Human
    Figure 10. Product Picture of Animal
    Figure 11. Global Vaccines Administered Orally Sales Market Share by Type in 2021
    Figure 12. Global Vaccines Administered Orally Revenue Market Share by Type (2017-2022)
    Figure 13. Vaccines Administered Orally Consumed in Public
    Figure 14. Global Vaccines Administered Orally Market: Public (2017-2022) & (K Units)
    Figure 15. Vaccines Administered Orally Consumed in Private
    Figure 16. Global Vaccines Administered Orally Market: Private (2017-2022) & (K Units)
    Figure 17. Global Vaccines Administered Orally Sales Market Share by Application (2017-2022)
    Figure 18. Global Vaccines Administered Orally Revenue Market Share by Application in 2021
    Figure 19. Vaccines Administered Orally Revenue Market by Company in 2021 ($ Million)
    Figure 20. Global Vaccines Administered Orally Revenue Market Share by Company in 2021
    Figure 21. Global Vaccines Administered Orally Sales Market Share by Geographic Region (2017-2022)
    Figure 22. Global Vaccines Administered Orally Revenue Market Share by Geographic Region in 2021
    Figure 23. Global Vaccines Administered Orally Sales Market Share by Region (2017-2022)
    Figure 24. Global Vaccines Administered Orally Revenue Market Share by Country/Region in 2021
    Figure 25. Americas Vaccines Administered Orally Sales 2017-2022 (K Units)
    Figure 26. Americas Vaccines Administered Orally Revenue 2017-2022 ($ Millions)
    Figure 27. APAC Vaccines Administered Orally Sales 2017-2022 (K Units)
    Figure 28. APAC Vaccines Administered Orally Revenue 2017-2022 ($ Millions)
    Figure 29. Europe Vaccines Administered Orally Sales 2017-2022 (K Units)
    Figure 30. Europe Vaccines Administered Orally Revenue 2017-2022 ($ Millions)
    Figure 31. Middle East & Africa Vaccines Administered Orally Sales 2017-2022 (K Units)
    Figure 32. Middle East & Africa Vaccines Administered Orally Revenue 2017-2022 ($ Millions)
    Figure 33. Americas Vaccines Administered Orally Sales Market Share by Country in 2021
    Figure 34. Americas Vaccines Administered Orally Revenue Market Share by Country in 2021
    Figure 35. United States Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 36. Canada Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 37. Mexico Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Brazil Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 39. APAC Vaccines Administered Orally Sales Market Share by Region in 2021
    Figure 40. APAC Vaccines Administered Orally Revenue Market Share by Regions in 2021
    Figure 41. China Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Japan Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 43. South Korea Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Southeast Asia Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 45. India Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Australia Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Europe Vaccines Administered Orally Sales Market Share by Country in 2021
    Figure 48. Europe Vaccines Administered Orally Revenue Market Share by Country in 2021
    Figure 49. Germany Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 50. France Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 51. UK Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Italy Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Russia Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Middle East & Africa Vaccines Administered Orally Sales Market Share by Country in 2021
    Figure 55. Middle East & Africa Vaccines Administered Orally Revenue Market Share by Country in 2021
    Figure 56. Egypt Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 57. South Africa Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Israel Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Turkey Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 60. GCC Country Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Manufacturing Cost Structure Analysis of Vaccines Administered Orally in 2021
    Figure 62. Manufacturing Process Analysis of Vaccines Administered Orally
    Figure 63. Industry Chain Structure of Vaccines Administered Orally
    Figure 64. Channels of Distribution
    Figure 65. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Vaccines Administered Orally Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Vaccines Administered Orally Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Vaccines Administered Orally Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports